Ashiq Mubarack

Stock Analyst at Citigroup

(0.87)
# 3,938
Out of 5,033 analysts
3
Total ratings
66.67%
Success rate
-18.49%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Ashiq Mubarack

Mersana Therapeutics
Aug 27, 2024
Maintains: Buy
Price Target: $150$125
Current: $10.42
Upside: +1,099.62%
Alpha Tau Medical
Dec 15, 2023
Initiates: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%